nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCB1—ovarian cancer	0.142	1	CbGaD
Glyburide—SLCO1A2—Chlorambucil—ovarian cancer	0.0885	0.143	CbGbCtD
Glyburide—ABCB11—Paclitaxel—ovarian cancer	0.0479	0.0775	CbGbCtD
Glyburide—ABCG2—Topotecan—ovarian cancer	0.046	0.0744	CbGbCtD
Glyburide—ABCC1—Epirubicin—ovarian cancer	0.0345	0.0558	CbGbCtD
Glyburide—ABCC1—Paclitaxel—ovarian cancer	0.034	0.0551	CbGbCtD
Glyburide—SLC22A7—Docetaxel—ovarian cancer	0.0313	0.0507	CbGbCtD
Glyburide—ABCC3—Doxorubicin—ovarian cancer	0.0298	0.0483	CbGbCtD
Glyburide—ABCB11—Doxorubicin—ovarian cancer	0.0258	0.0418	CbGbCtD
Glyburide—ABCC2—Paclitaxel—ovarian cancer	0.0252	0.0408	CbGbCtD
Glyburide—ABCC1—Docetaxel—ovarian cancer	0.0246	0.0398	CbGbCtD
Glyburide—ABCC2—Carboplatin—ovarian cancer	0.0237	0.0384	CbGbCtD
Glyburide—ABCG2—Paclitaxel—ovarian cancer	0.0228	0.0368	CbGbCtD
Glyburide—ABCG2—Carboplatin—ovarian cancer	0.0214	0.0347	CbGbCtD
Glyburide—ABCC1—Doxorubicin—ovarian cancer	0.0183	0.0297	CbGbCtD
Glyburide—ABCC2—Docetaxel—ovarian cancer	0.0182	0.0295	CbGbCtD
Glyburide—ABCB1—Topotecan—ovarian cancer	0.0166	0.0268	CbGbCtD
Glyburide—ABCG2—Docetaxel—ovarian cancer	0.0165	0.0266	CbGbCtD
Glyburide—ABCC2—Doxorubicin—ovarian cancer	0.0136	0.022	CbGbCtD
Glyburide—ABCG2—Doxorubicin—ovarian cancer	0.0123	0.0199	CbGbCtD
Glyburide—ABCB1—Vinorelbine—ovarian cancer	0.0117	0.0189	CbGbCtD
Glyburide—CYP3A4—Topotecan—ovarian cancer	0.00993	0.0161	CbGbCtD
Glyburide—CYP2C9—Paclitaxel—ovarian cancer	0.00845	0.0137	CbGbCtD
Glyburide—ABCB1—Paclitaxel—ovarian cancer	0.00821	0.0133	CbGbCtD
Glyburide—CYP3A4—Vinorelbine—ovarian cancer	0.007	0.0113	CbGbCtD
Glyburide—ABCB1—Docetaxel—ovarian cancer	0.00593	0.00961	CbGbCtD
Glyburide—CYP3A4—Paclitaxel—ovarian cancer	0.00492	0.00796	CbGbCtD
Glyburide—ABCB1—Doxorubicin—ovarian cancer	0.00442	0.00716	CbGbCtD
Glyburide—CYP3A4—Docetaxel—ovarian cancer	0.00355	0.00576	CbGbCtD
Glyburide—CYP3A4—Doxorubicin—ovarian cancer	0.00265	0.00429	CbGbCtD
Glyburide—ABCC9—female gonad—ovarian cancer	0.00172	0.0312	CbGeAlD
Glyburide—ABCA1—decidua—ovarian cancer	0.00163	0.0296	CbGeAlD
Glyburide—CFTR—epithelium—ovarian cancer	0.00163	0.0296	CbGeAlD
Glyburide—CPT1A—gonad—ovarian cancer	0.00154	0.028	CbGeAlD
Glyburide—ABCC9—testis—ovarian cancer	0.00152	0.0277	CbGeAlD
Glyburide—CPT1A—female reproductive system—ovarian cancer	0.00137	0.025	CbGeAlD
Glyburide—ABCA1—female reproductive system—ovarian cancer	0.00128	0.0233	CbGeAlD
Glyburide—CPT1A—female gonad—ovarian cancer	0.00125	0.0227	CbGeAlD
Glyburide—CPT1A—vagina—ovarian cancer	0.00124	0.0226	CbGeAlD
Glyburide—CFTR—female reproductive system—ovarian cancer	0.00121	0.022	CbGeAlD
Glyburide—Gliclazide—VEGFA—ovarian cancer	0.00121	0.834	CrCbGaD
Glyburide—ABCA1—female gonad—ovarian cancer	0.00116	0.0212	CbGeAlD
Glyburide—ABCA1—vagina—ovarian cancer	0.00116	0.021	CbGeAlD
Glyburide—CPT1A—testis—ovarian cancer	0.00111	0.0202	CbGeAlD
Glyburide—ABCC9—lymph node—ovarian cancer	0.0011	0.0201	CbGeAlD
Glyburide—CFTR—female gonad—ovarian cancer	0.0011	0.02	CbGeAlD
Glyburide—ABCA1—testis—ovarian cancer	0.00103	0.0188	CbGeAlD
Glyburide—CFTR—testis—ovarian cancer	0.000974	0.0177	CbGeAlD
Glyburide—SLC15A1—epithelium—ovarian cancer	0.000966	0.0176	CbGeAlD
Glyburide—ABCC8—endometrium—ovarian cancer	0.000906	0.0165	CbGeAlD
Glyburide—SLC15A1—endometrium—ovarian cancer	0.000866	0.0158	CbGeAlD
Glyburide—KCNJ11—female reproductive system—ovarian cancer	0.000815	0.0148	CbGeAlD
Glyburide—CPT1A—lymph node—ovarian cancer	0.000802	0.0146	CbGeAlD
Glyburide—ABCC3—decidua—ovarian cancer	0.000801	0.0146	CbGeAlD
Glyburide—ABCB11—testis—ovarian cancer	0.000799	0.0146	CbGeAlD
Glyburide—ABCC1—myometrium—ovarian cancer	0.000761	0.0139	CbGeAlD
Glyburide—ABCA1—lymph node—ovarian cancer	0.000748	0.0136	CbGeAlD
Glyburide—SLCO2B1—decidua—ovarian cancer	0.000747	0.0136	CbGeAlD
Glyburide—KCNJ11—female gonad—ovarian cancer	0.000741	0.0135	CbGeAlD
Glyburide—SLC22A7—testis—ovarian cancer	0.000721	0.0131	CbGeAlD
Glyburide—SLCO2B1—uterus—ovarian cancer	0.000653	0.0119	CbGeAlD
Glyburide—SLC15A1—vagina—ovarian cancer	0.000649	0.0118	CbGeAlD
Glyburide—ABCC3—female reproductive system—ovarian cancer	0.00063	0.0115	CbGeAlD
Glyburide—ABCG2—myometrium—ovarian cancer	0.00063	0.0115	CbGeAlD
Glyburide—ABCC8—testis—ovarian cancer	0.000606	0.011	CbGeAlD
Glyburide—SLC15A2—uterine cervix—ovarian cancer	0.000599	0.0109	CbGeAlD
Glyburide—ABCC1—uterine cervix—ovarian cancer	0.000592	0.0108	CbGeAlD
Glyburide—SLCO2B1—female reproductive system—ovarian cancer	0.000587	0.0107	CbGeAlD
Glyburide—ABCC3—female gonad—ovarian cancer	0.000573	0.0104	CbGeAlD
Glyburide—ABCC1—decidua—ovarian cancer	0.000564	0.0103	CbGeAlD
Glyburide—SLC15A2—endometrium—ovarian cancer	0.000541	0.00986	CbGeAlD
Glyburide—ABCC1—endometrium—ovarian cancer	0.000535	0.00975	CbGeAlD
Glyburide—SLCO2B1—female gonad—ovarian cancer	0.000534	0.00973	CbGeAlD
Glyburide—ABCC3—testis—ovarian cancer	0.000509	0.00926	CbGeAlD
Glyburide—ABCC2—female reproductive system—ovarian cancer	0.000504	0.00917	CbGeAlD
Glyburide—ABCC1—uterus—ovarian cancer	0.000493	0.00898	CbGeAlD
Glyburide—ABCG2—uterine cervix—ovarian cancer	0.00049	0.00892	CbGeAlD
Glyburide—KCNJ11—lymph node—ovarian cancer	0.000477	0.00868	CbGeAlD
Glyburide—SLCO2B1—testis—ovarian cancer	0.000474	0.00863	CbGeAlD
Glyburide—ABCG2—decidua—ovarian cancer	0.000467	0.0085	CbGeAlD
Glyburide—SLC15A2—female reproductive system—ovarian cancer	0.000449	0.00817	CbGeAlD
Glyburide—ABCG2—endometrium—ovarian cancer	0.000443	0.00807	CbGeAlD
Glyburide—SLCO1A2—testis—ovarian cancer	0.000436	0.00794	CbGeAlD
Glyburide—ALB—testis—ovarian cancer	0.000434	0.0079	CbGeAlD
Glyburide—ABCG2—uterus—ovarian cancer	0.000408	0.00744	CbGeAlD
Glyburide—SLC15A2—female gonad—ovarian cancer	0.000408	0.00743	CbGeAlD
Glyburide—ABCC2—testis—ovarian cancer	0.000406	0.0074	CbGeAlD
Glyburide—SLC15A2—vagina—ovarian cancer	0.000406	0.00739	CbGeAlD
Glyburide—ABCC1—female gonad—ovarian cancer	0.000404	0.00735	CbGeAlD
Glyburide—ABCC1—vagina—ovarian cancer	0.000401	0.0073	CbGeAlD
Glyburide—CYP2C19—vagina—ovarian cancer	0.000391	0.00712	CbGeAlD
Glyburide—ABCC3—lymph node—ovarian cancer	0.000369	0.00671	CbGeAlD
Glyburide—SLC15A2—testis—ovarian cancer	0.000362	0.00659	CbGeAlD
Glyburide—ABCC1—testis—ovarian cancer	0.000358	0.00652	CbGeAlD
Glyburide—ABCG2—bone marrow—ovarian cancer	0.000347	0.00631	CbGeAlD
Glyburide—SLCO2B1—lymph node—ovarian cancer	0.000344	0.00626	CbGeAlD
Glyburide—CYP2C9—female reproductive system—ovarian cancer	0.000335	0.00611	CbGeAlD
Glyburide—ABCG2—female gonad—ovarian cancer	0.000334	0.00608	CbGeAlD
Glyburide—ABCG2—vagina—ovarian cancer	0.000332	0.00605	CbGeAlD
Glyburide—ALB—lymph node—ovarian cancer	0.000314	0.00572	CbGeAlD
Glyburide—ABCB1—myometrium—ovarian cancer	0.000311	0.00565	CbGeAlD
Glyburide—ABCB1—embryo—ovarian cancer	0.000299	0.00544	CbGeAlD
Glyburide—ABCG2—testis—ovarian cancer	0.000296	0.0054	CbGeAlD
Glyburide—ABCC2—lymph node—ovarian cancer	0.000295	0.00536	CbGeAlD
Glyburide—Paraesthesia—Melphalan—ovarian cancer	0.000282	0.00225	CcSEcCtD
Glyburide—Dyspnoea—Melphalan—ovarian cancer	0.00028	0.00223	CcSEcCtD
Glyburide—Decreased appetite—Topotecan—ovarian cancer	0.000279	0.00223	CcSEcCtD
Glyburide—Aplastic anaemia—Epirubicin—ovarian cancer	0.000278	0.00222	CcSEcCtD
Glyburide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000277	0.00221	CcSEcCtD
Glyburide—Dyspepsia—Melphalan—ovarian cancer	0.000276	0.00221	CcSEcCtD
Glyburide—Decreased appetite—Melphalan—ovarian cancer	0.000273	0.00218	CcSEcCtD
Glyburide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000271	0.00216	CcSEcCtD
Glyburide—Nervous system disorder—Vinorelbine—ovarian cancer	0.000269	0.00215	CcSEcCtD
Glyburide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000268	0.00214	CcSEcCtD
Glyburide—Hypersensitivity—Chlorambucil—ovarian cancer	0.000265	0.00212	CcSEcCtD
Glyburide—Feeling abnormal—Topotecan—ovarian cancer	0.000264	0.00211	CcSEcCtD
Glyburide—SLC15A2—lymph node—ovarian cancer	0.000262	0.00478	CbGeAlD
Glyburide—Gastrointestinal pain—Topotecan—ovarian cancer	0.000262	0.00209	CcSEcCtD
Glyburide—Anorexia—Vinorelbine—ovarian cancer	0.000261	0.00209	CcSEcCtD
Glyburide—Pancytopenia—Docetaxel—ovarian cancer	0.000261	0.00208	CcSEcCtD
Glyburide—ABCC1—lymph node—ovarian cancer	0.000259	0.00472	CbGeAlD
Glyburide—Asthenia—Chlorambucil—ovarian cancer	0.000258	0.00206	CcSEcCtD
Glyburide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000257	0.00205	CcSEcCtD
Glyburide—Hypotension—Vinorelbine—ovarian cancer	0.000256	0.00205	CcSEcCtD
Glyburide—CYP3A4—female reproductive system—ovarian cancer	0.000256	0.00466	CbGeAlD
Glyburide—Pruritus—Chlorambucil—ovarian cancer	0.000255	0.00203	CcSEcCtD
Glyburide—Urticaria—Topotecan—ovarian cancer	0.000255	0.00203	CcSEcCtD
Glyburide—Abdominal pain—Topotecan—ovarian cancer	0.000253	0.00202	CcSEcCtD
Glyburide—Visual impairment—Paclitaxel—ovarian cancer	0.00025	0.002	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00025	0.00199	CcSEcCtD
Glyburide—Urticaria—Melphalan—ovarian cancer	0.000249	0.00199	CcSEcCtD
Glyburide—Diarrhoea—Chlorambucil—ovarian cancer	0.000246	0.00197	CcSEcCtD
Glyburide—Paraesthesia—Vinorelbine—ovarian cancer	0.000246	0.00197	CcSEcCtD
Glyburide—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000246	0.00196	CcSEcCtD
Glyburide—Dyspnoea—Vinorelbine—ovarian cancer	0.000244	0.00195	CcSEcCtD
Glyburide—ABCB1—epithelium—ovarian cancer	0.000244	0.00444	CbGeAlD
Glyburide—Eye disorder—Paclitaxel—ovarian cancer	0.000243	0.00194	CcSEcCtD
Glyburide—ABCB1—uterine cervix—ovarian cancer	0.000242	0.0044	CbGeAlD
Glyburide—Chlorpropamide—ABCB1—ovarian cancer	0.00024	0.166	CrCbGaD
Glyburide—Vascular purpura—Epirubicin—ovarian cancer	0.00024	0.00192	CcSEcCtD
Glyburide—Jaundice—Docetaxel—ovarian cancer	0.000239	0.00191	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—ovarian cancer	0.000239	0.00191	CcSEcCtD
Glyburide—Decreased appetite—Vinorelbine—ovarian cancer	0.000238	0.0019	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000237	0.00189	CcSEcCtD
Glyburide—Hypersensitivity—Topotecan—ovarian cancer	0.000236	0.00189	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—ovarian cancer	0.000232	0.00186	CcSEcCtD
Glyburide—Hypersensitivity—Melphalan—ovarian cancer	0.000231	0.00185	CcSEcCtD
Glyburide—ABCB1—decidua—ovarian cancer	0.00023	0.00419	CbGeAlD
Glyburide—Asthenia—Topotecan—ovarian cancer	0.00023	0.00184	CcSEcCtD
Glyburide—Alopecia—Paclitaxel—ovarian cancer	0.000229	0.00183	CcSEcCtD
Glyburide—Vomiting—Chlorambucil—ovarian cancer	0.000229	0.00183	CcSEcCtD
Glyburide—Agranulocytosis—Docetaxel—ovarian cancer	0.000229	0.00183	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000227	0.00181	CcSEcCtD
Glyburide—Pruritus—Topotecan—ovarian cancer	0.000227	0.00181	CcSEcCtD
Glyburide—Erythema—Paclitaxel—ovarian cancer	0.000226	0.0018	CcSEcCtD
Glyburide—Malnutrition—Paclitaxel—ovarian cancer	0.000226	0.0018	CcSEcCtD
Glyburide—Feeling abnormal—Vinorelbine—ovarian cancer	0.000226	0.0018	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—ovarian cancer	0.000225	0.0018	CcSEcCtD
Glyburide—Asthenia—Melphalan—ovarian cancer	0.000225	0.0018	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—ovarian cancer	0.000224	0.00179	CcSEcCtD
Glyburide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000224	0.00179	CcSEcCtD
Glyburide—Purpura—Epirubicin—ovarian cancer	0.000223	0.00178	CcSEcCtD
Glyburide—Pruritus—Melphalan—ovarian cancer	0.000222	0.00177	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—ovarian cancer	0.000222	0.00177	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—ovarian cancer	0.000221	0.00176	CcSEcCtD
Glyburide—Hepatitis—Docetaxel—ovarian cancer	0.00022	0.00176	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—ovarian cancer	0.00022	0.00176	CcSEcCtD
Glyburide—Diarrhoea—Topotecan—ovarian cancer	0.000219	0.00175	CcSEcCtD
Glyburide—ABCB1—endometrium—ovarian cancer	0.000219	0.00398	CbGeAlD
Glyburide—Urticaria—Vinorelbine—ovarian cancer	0.000218	0.00174	CcSEcCtD
Glyburide—Abdominal pain—Vinorelbine—ovarian cancer	0.000217	0.00173	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—ovarian cancer	0.000215	0.00172	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—ovarian cancer	0.000215	0.00172	CcSEcCtD
Glyburide—ABCG2—lymph node—ovarian cancer	0.000215	0.00391	CbGeAlD
Glyburide—Diarrhoea—Melphalan—ovarian cancer	0.000215	0.00171	CcSEcCtD
Glyburide—Diplopia—Epirubicin—ovarian cancer	0.000215	0.00171	CcSEcCtD
Glyburide—Nausea—Chlorambucil—ovarian cancer	0.000214	0.00171	CcSEcCtD
Glyburide—Vision blurred—Paclitaxel—ovarian cancer	0.000213	0.0017	CcSEcCtD
Glyburide—Visual impairment—Docetaxel—ovarian cancer	0.000212	0.00169	CcSEcCtD
Glyburide—Tremor—Paclitaxel—ovarian cancer	0.000212	0.00169	CcSEcCtD
Glyburide—Anaemia—Paclitaxel—ovarian cancer	0.000209	0.00167	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—ovarian cancer	0.000209	0.00167	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000208	0.00166	CcSEcCtD
Glyburide—Angioedema—Paclitaxel—ovarian cancer	0.000207	0.00165	CcSEcCtD
Glyburide—Purpura—Doxorubicin—ovarian cancer	0.000206	0.00164	CcSEcCtD
Glyburide—Eye disorder—Docetaxel—ovarian cancer	0.000206	0.00164	CcSEcCtD
Glyburide—Vomiting—Topotecan—ovarian cancer	0.000204	0.00163	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000203	0.00162	CcSEcCtD
Glyburide—ABCB1—gonad—ovarian cancer	0.000203	0.00369	CbGeAlD
Glyburide—Leukopenia—Paclitaxel—ovarian cancer	0.000202	0.00162	CcSEcCtD
Glyburide—Rash—Topotecan—ovarian cancer	0.000202	0.00161	CcSEcCtD
Glyburide—Hypersensitivity—Vinorelbine—ovarian cancer	0.000202	0.00161	CcSEcCtD
Glyburide—Dermatitis—Topotecan—ovarian cancer	0.000202	0.00161	CcSEcCtD
Glyburide—ABCB1—uterus—ovarian cancer	0.000201	0.00367	CbGeAlD
Glyburide—Headache—Topotecan—ovarian cancer	0.000201	0.0016	CcSEcCtD
Glyburide—Vomiting—Melphalan—ovarian cancer	0.0002	0.00159	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—ovarian cancer	0.000199	0.00159	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—ovarian cancer	0.000199	0.00159	CcSEcCtD
Glyburide—Rash—Melphalan—ovarian cancer	0.000198	0.00158	CcSEcCtD
Glyburide—Dermatitis—Melphalan—ovarian cancer	0.000198	0.00158	CcSEcCtD
Glyburide—Asthenia—Vinorelbine—ovarian cancer	0.000197	0.00157	CcSEcCtD
Glyburide—Convulsion—Paclitaxel—ovarian cancer	0.000196	0.00156	CcSEcCtD
Glyburide—Alopecia—Docetaxel—ovarian cancer	0.000194	0.00155	CcSEcCtD
Glyburide—Pruritus—Vinorelbine—ovarian cancer	0.000194	0.00155	CcSEcCtD
Glyburide—Arthralgia—Paclitaxel—ovarian cancer	0.000192	0.00154	CcSEcCtD
Glyburide—Myalgia—Paclitaxel—ovarian cancer	0.000192	0.00154	CcSEcCtD
Glyburide—Malnutrition—Docetaxel—ovarian cancer	0.000192	0.00153	CcSEcCtD
Glyburide—Erythema—Docetaxel—ovarian cancer	0.000192	0.00153	CcSEcCtD
Glyburide—Nausea—Topotecan—ovarian cancer	0.00019	0.00152	CcSEcCtD
Glyburide—Diarrhoea—Vinorelbine—ovarian cancer	0.000188	0.0015	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—ovarian cancer	0.000187	0.00149	CcSEcCtD
Glyburide—Nausea—Melphalan—ovarian cancer	0.000186	0.00149	CcSEcCtD
Glyburide—Confusional state—Paclitaxel—ovarian cancer	0.000186	0.00148	CcSEcCtD
Glyburide—Oedema—Paclitaxel—ovarian cancer	0.000184	0.00147	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—ovarian cancer	0.000184	0.00147	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—ovarian cancer	0.000182	0.00145	CcSEcCtD
Glyburide—Shock—Paclitaxel—ovarian cancer	0.000181	0.00145	CcSEcCtD
Glyburide—ABCB1—female reproductive system—ovarian cancer	0.000181	0.0033	CbGeAlD
Glyburide—Nervous system disorder—Paclitaxel—ovarian cancer	0.000181	0.00144	CcSEcCtD
Glyburide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000181	0.00144	CcSEcCtD
Glyburide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000178	0.00142	CcSEcCtD
Glyburide—Anaemia—Docetaxel—ovarian cancer	0.000177	0.00141	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—ovarian cancer	0.000176	0.00141	CcSEcCtD
Glyburide—Anorexia—Paclitaxel—ovarian cancer	0.000176	0.0014	CcSEcCtD
Glyburide—Vomiting—Vinorelbine—ovarian cancer	0.000174	0.00139	CcSEcCtD
Glyburide—Rash—Vinorelbine—ovarian cancer	0.000173	0.00138	CcSEcCtD
Glyburide—Dermatitis—Vinorelbine—ovarian cancer	0.000173	0.00138	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—ovarian cancer	0.000173	0.00138	CcSEcCtD
Glyburide—Hypotension—Paclitaxel—ovarian cancer	0.000172	0.00138	CcSEcCtD
Glyburide—Headache—Vinorelbine—ovarian cancer	0.000172	0.00137	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—ovarian cancer	0.000171	0.00137	CcSEcCtD
Glyburide—ABCB1—bone marrow—ovarian cancer	0.000171	0.00311	CbGeAlD
Glyburide—Eosinophilia—Doxorubicin—ovarian cancer	0.00017	0.00136	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000169	0.00135	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—ovarian cancer	0.000168	0.00134	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000168	0.00134	CcSEcCtD
Glyburide—Convulsion—Docetaxel—ovarian cancer	0.000166	0.00133	CcSEcCtD
Glyburide—Paraesthesia—Paclitaxel—ovarian cancer	0.000166	0.00132	CcSEcCtD
Glyburide—ABCB1—female gonad—ovarian cancer	0.000165	0.003	CbGeAlD
Glyburide—Dyspnoea—Paclitaxel—ovarian cancer	0.000164	0.00131	CcSEcCtD
Glyburide—ABCB1—vagina—ovarian cancer	0.000164	0.00298	CbGeAlD
Glyburide—Myalgia—Docetaxel—ovarian cancer	0.000163	0.0013	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—ovarian cancer	0.000163	0.0013	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—ovarian cancer	0.000163	0.0013	CcSEcCtD
Glyburide—Nausea—Vinorelbine—ovarian cancer	0.000163	0.0013	CcSEcCtD
Glyburide—Dyspepsia—Paclitaxel—ovarian cancer	0.000162	0.0013	CcSEcCtD
Glyburide—Jaundice—Epirubicin—ovarian cancer	0.000161	0.00129	CcSEcCtD
Glyburide—Decreased appetite—Paclitaxel—ovarian cancer	0.00016	0.00128	CcSEcCtD
Glyburide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000159	0.00127	CcSEcCtD
Glyburide—Confusional state—Docetaxel—ovarian cancer	0.000158	0.00126	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000157	0.00125	CcSEcCtD
Glyburide—Oedema—Docetaxel—ovarian cancer	0.000156	0.00125	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—ovarian cancer	0.000154	0.00123	CcSEcCtD
Glyburide—Shock—Docetaxel—ovarian cancer	0.000154	0.00123	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—ovarian cancer	0.000153	0.00122	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000153	0.00122	CcSEcCtD
Glyburide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000152	0.00121	CcSEcCtD
Glyburide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000151	0.0012	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—ovarian cancer	0.000149	0.00119	CcSEcCtD
Glyburide—Anorexia—Docetaxel—ovarian cancer	0.000149	0.00119	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—ovarian cancer	0.000148	0.00119	CcSEcCtD
Glyburide—Urticaria—Paclitaxel—ovarian cancer	0.000147	0.00117	CcSEcCtD
Glyburide—ABCB1—testis—ovarian cancer	0.000146	0.00266	CbGeAlD
Glyburide—Hypotension—Docetaxel—ovarian cancer	0.000146	0.00117	CcSEcCtD
Glyburide—Abdominal pain—Paclitaxel—ovarian cancer	0.000146	0.00116	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—ovarian cancer	0.000143	0.00114	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000143	0.00114	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000142	0.00114	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—ovarian cancer	0.00014	0.00112	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—ovarian cancer	0.000139	0.00111	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—ovarian cancer	0.000139	0.00111	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—ovarian cancer	0.000138	0.0011	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—ovarian cancer	0.000137	0.0011	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—ovarian cancer	0.000136	0.00109	CcSEcCtD
Glyburide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000136	0.00109	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000135	0.00108	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—ovarian cancer	0.000132	0.00106	CcSEcCtD
Glyburide—Asthenia—Paclitaxel—ovarian cancer	0.000132	0.00106	CcSEcCtD
Glyburide—Alopecia—Epirubicin—ovarian cancer	0.000131	0.00105	CcSEcCtD
Glyburide—Pruritus—Paclitaxel—ovarian cancer	0.00013	0.00104	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—ovarian cancer	0.000129	0.00103	CcSEcCtD
Glyburide—Erythema—Epirubicin—ovarian cancer	0.000129	0.00103	CcSEcCtD
Glyburide—Feeling abnormal—Docetaxel—ovarian cancer	0.000129	0.00103	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—ovarian cancer	0.000128	0.00102	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000128	0.00102	CcSEcCtD
Glyburide—Diarrhoea—Paclitaxel—ovarian cancer	0.000126	0.00101	CcSEcCtD
Glyburide—Abdominal pain—Docetaxel—ovarian cancer	0.000124	0.000987	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—ovarian cancer	0.000122	0.000972	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—ovarian cancer	0.000121	0.000969	CcSEcCtD
Glyburide—Erythema—Doxorubicin—ovarian cancer	0.00012	0.000955	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—ovarian cancer	0.00012	0.000955	CcSEcCtD
Glyburide—Anaemia—Epirubicin—ovarian cancer	0.000119	0.000954	CcSEcCtD
Glyburide—Vomiting—Paclitaxel—ovarian cancer	0.000117	0.000936	CcSEcCtD
Glyburide—Rash—Paclitaxel—ovarian cancer	0.000116	0.000929	CcSEcCtD
Glyburide—Dermatitis—Paclitaxel—ovarian cancer	0.000116	0.000928	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—ovarian cancer	0.000116	0.000923	CcSEcCtD
Glyburide—Headache—Paclitaxel—ovarian cancer	0.000116	0.000923	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—ovarian cancer	0.000115	0.00092	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—ovarian cancer	0.000113	0.0009	CcSEcCtD
Glyburide—Asthenia—Docetaxel—ovarian cancer	0.000112	0.000896	CcSEcCtD
Glyburide—Convulsion—Epirubicin—ovarian cancer	0.000112	0.000894	CcSEcCtD
Glyburide—Pruritus—Docetaxel—ovarian cancer	0.000111	0.000883	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—ovarian cancer	0.000111	0.000882	CcSEcCtD
Glyburide—Myalgia—Epirubicin—ovarian cancer	0.00011	0.000878	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—ovarian cancer	0.00011	0.000878	CcSEcCtD
Glyburide—Nausea—Paclitaxel—ovarian cancer	0.00011	0.000875	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—ovarian cancer	0.000107	0.000854	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—ovarian cancer	0.000107	0.000854	CcSEcCtD
Glyburide—Confusional state—Epirubicin—ovarian cancer	0.000106	0.000849	CcSEcCtD
Glyburide—ABCB1—lymph node—ovarian cancer	0.000106	0.00193	CbGeAlD
Glyburide—Oedema—Epirubicin—ovarian cancer	0.000105	0.000842	CcSEcCtD
Glyburide—Shock—Epirubicin—ovarian cancer	0.000104	0.000828	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—ovarian cancer	0.000104	0.000827	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—ovarian cancer	0.000103	0.000826	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000103	0.000824	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000102	0.000814	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—ovarian cancer	0.000102	0.000813	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—ovarian cancer	0.000102	0.000813	CcSEcCtD
Glyburide—Anorexia—Epirubicin—ovarian cancer	0.000101	0.000803	CcSEcCtD
Glyburide—Vomiting—Docetaxel—ovarian cancer	9.94e-05	0.000794	CcSEcCtD
Glyburide—Rash—Docetaxel—ovarian cancer	9.86e-05	0.000787	CcSEcCtD
Glyburide—Hypotension—Epirubicin—ovarian cancer	9.85e-05	0.000787	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—ovarian cancer	9.85e-05	0.000786	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—ovarian cancer	9.84e-05	0.000786	CcSEcCtD
Glyburide—Headache—Docetaxel—ovarian cancer	9.79e-05	0.000782	CcSEcCtD
Glyburide—Oedema—Doxorubicin—ovarian cancer	9.76e-05	0.000779	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.61e-05	0.000767	CcSEcCtD
Glyburide—Shock—Doxorubicin—ovarian cancer	9.6e-05	0.000766	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—ovarian cancer	9.57e-05	0.000764	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—ovarian cancer	9.55e-05	0.000763	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—ovarian cancer	9.47e-05	0.000756	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—ovarian cancer	9.43e-05	0.000753	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—ovarian cancer	9.4e-05	0.000751	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—ovarian cancer	9.3e-05	0.000743	CcSEcCtD
Glyburide—Nausea—Docetaxel—ovarian cancer	9.29e-05	0.000741	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—ovarian cancer	9.28e-05	0.000741	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—ovarian cancer	9.17e-05	0.000732	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—ovarian cancer	9.12e-05	0.000728	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.1e-05	0.000727	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.89e-05	0.00071	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—ovarian cancer	8.76e-05	0.0007	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—ovarian cancer	8.7e-05	0.000695	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—ovarian cancer	8.69e-05	0.000694	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—ovarian cancer	8.62e-05	0.000689	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—ovarian cancer	8.59e-05	0.000686	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—ovarian cancer	8.48e-05	0.000677	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.42e-05	0.000673	CcSEcCtD
Glyburide—Urticaria—Epirubicin—ovarian cancer	8.38e-05	0.000669	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—ovarian cancer	8.34e-05	0.000666	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—ovarian cancer	8.04e-05	0.000642	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.98e-05	0.000637	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—ovarian cancer	7.77e-05	0.00062	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—ovarian cancer	7.75e-05	0.000619	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—ovarian cancer	7.71e-05	0.000616	CcSEcCtD
Glyburide—Asthenia—Epirubicin—ovarian cancer	7.57e-05	0.000604	CcSEcCtD
Glyburide—Pruritus—Epirubicin—ovarian cancer	7.46e-05	0.000596	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—ovarian cancer	7.22e-05	0.000576	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—ovarian cancer	7.19e-05	0.000574	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—ovarian cancer	7e-05	0.000559	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—ovarian cancer	6.9e-05	0.000551	CcSEcCtD
Glyburide—Vomiting—Epirubicin—ovarian cancer	6.7e-05	0.000535	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—ovarian cancer	6.68e-05	0.000533	CcSEcCtD
Glyburide—Rash—Epirubicin—ovarian cancer	6.65e-05	0.000531	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—ovarian cancer	6.64e-05	0.00053	CcSEcCtD
Glyburide—Headache—Epirubicin—ovarian cancer	6.61e-05	0.000527	CcSEcCtD
Glyburide—Nausea—Epirubicin—ovarian cancer	6.26e-05	0.0005	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—ovarian cancer	6.2e-05	0.000495	CcSEcCtD
Glyburide—Rash—Doxorubicin—ovarian cancer	6.15e-05	0.000491	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—ovarian cancer	6.15e-05	0.000491	CcSEcCtD
Glyburide—Headache—Doxorubicin—ovarian cancer	6.11e-05	0.000488	CcSEcCtD
Glyburide—Nausea—Doxorubicin—ovarian cancer	5.8e-05	0.000463	CcSEcCtD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.38e-05	0.000234	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ABCB1—ovarian cancer	1.38e-05	0.000233	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.38e-05	0.000233	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.38e-05	0.000233	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYTB—ovarian cancer	1.38e-05	0.000233	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.38e-05	0.000232	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPP1CC—ovarian cancer	1.37e-05	0.000232	CbGpPWpGaD
Glyburide—ALB—Metabolism—BRIP1—ovarian cancer	1.37e-05	0.000232	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.37e-05	0.000231	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.36e-05	0.00023	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TYMS—ovarian cancer	1.36e-05	0.000229	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTEN—ovarian cancer	1.35e-05	0.000228	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTEN—ovarian cancer	1.35e-05	0.000228	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.35e-05	0.000228	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CAV1—ovarian cancer	1.34e-05	0.000227	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.33e-05	0.000226	CbGpPWpGaD
Glyburide—ABCC1—Disease—PPP2R1A—ovarian cancer	1.33e-05	0.000225	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ABCB1—ovarian cancer	1.32e-05	0.000224	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NME2—ovarian cancer	1.32e-05	0.000222	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.31e-05	0.000222	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.31e-05	0.000222	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TYMS—ovarian cancer	1.3e-05	0.00022	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.3e-05	0.00022	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.29e-05	0.000217	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYTB—ovarian cancer	1.29e-05	0.000217	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.27e-05	0.000214	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.26e-05	0.000213	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CG—ovarian cancer	1.26e-05	0.000213	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.26e-05	0.000212	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.24e-05	0.00021	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.24e-05	0.000209	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.23e-05	0.000208	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.23e-05	0.000208	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CG—ovarian cancer	1.22e-05	0.000206	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—FASN—ovarian cancer	1.22e-05	0.000206	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BRIP1—ovarian cancer	1.2e-05	0.000203	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.2e-05	0.000203	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.2e-05	0.000203	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.2e-05	0.000202	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.16e-05	0.000196	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.16e-05	0.000195	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.15e-05	0.000195	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.14e-05	0.000193	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.13e-05	0.000191	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.12e-05	0.00019	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.12e-05	0.00019	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.12e-05	0.000189	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.11e-05	0.000188	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.11e-05	0.000187	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CD—ovarian cancer	1.11e-05	0.000187	CbGpPWpGaD
Glyburide—ALB—Hemostasis—CAV1—ovarian cancer	1.1e-05	0.000186	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.1e-05	0.000186	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CAV1—ovarian cancer	1.09e-05	0.000185	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.08e-05	0.000183	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CD—ovarian cancer	1.07e-05	0.000181	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—ovarian cancer	1.06e-05	0.000179	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.05e-05	0.000178	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CAV1—ovarian cancer	1.05e-05	0.000177	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.05e-05	0.000177	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.04e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ABCB1—ovarian cancer	1.04e-05	0.000175	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.03e-05	0.000174	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.03e-05	0.000174	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TYMS—ovarian cancer	1.02e-05	0.000172	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CG—ovarian cancer	1e-05	0.000169	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1e-05	0.000169	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1e-05	0.000169	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CG—ovarian cancer	9.96e-06	0.000168	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPP2R1A—ovarian cancer	9.83e-06	0.000166	CbGpPWpGaD
Glyburide—ABCC1—Disease—CAV1—ovarian cancer	9.8e-06	0.000166	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.73e-06	0.000164	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CB—ovarian cancer	9.65e-06	0.000163	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—ovarian cancer	9.55e-06	0.000161	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—ovarian cancer	9.52e-06	0.000161	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—ovarian cancer	9.52e-06	0.000161	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CB—ovarian cancer	9.36e-06	0.000158	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6ST—ovarian cancer	9.29e-06	0.000157	CbGpPWpGaD
Glyburide—ALB—Metabolism—YAP1—ovarian cancer	9.21e-06	0.000156	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—ovarian cancer	9.13e-06	0.000154	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CAV1—ovarian cancer	9.13e-06	0.000154	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.12e-06	0.000154	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.08e-06	0.000153	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.99e-06	0.000152	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TYMS—ovarian cancer	8.97e-06	0.000152	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.94e-06	0.000151	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—ovarian cancer	8.93e-06	0.000151	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CD—ovarian cancer	8.81e-06	0.000149	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CD—ovarian cancer	8.75e-06	0.000148	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.72e-06	0.000147	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.65e-06	0.000146	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYTB—ovarian cancer	8.48e-06	0.000143	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CD—ovarian cancer	8.39e-06	0.000142	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—ovarian cancer	8.34e-06	0.000141	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	8.31e-06	0.00014	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—YAP1—ovarian cancer	8.27e-06	0.00014	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CAV1—ovarian cancer	8.21e-06	0.000139	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.19e-06	0.000138	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.19e-06	0.000138	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—ovarian cancer	8.09e-06	0.000137	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—YAP1—ovarian cancer	8.07e-06	0.000136	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.02e-06	0.000135	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—ovarian cancer	7.85e-06	0.000133	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.84e-06	0.000133	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—ovarian cancer	7.78e-06	0.000131	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—ovarian cancer	7.78e-06	0.000131	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—ovarian cancer	7.67e-06	0.00013	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—ovarian cancer	7.63e-06	0.000129	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—YAP1—ovarian cancer	7.54e-06	0.000127	CbGpPWpGaD
Glyburide—ALB—Metabolism—FASN—ovarian cancer	7.51e-06	0.000127	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—ovarian cancer	7.48e-06	0.000126	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.46e-06	0.000126	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.42e-06	0.000125	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.42e-06	0.000125	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.41e-06	0.000125	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC5A5—ovarian cancer	7.39e-06	0.000125	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—ovarian cancer	7.31e-06	0.000124	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	7.31e-06	0.000123	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.3e-06	0.000123	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CAV1—ovarian cancer	7.23e-06	0.000122	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.2e-06	0.000122	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A1—ovarian cancer	7.14e-06	0.000121	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—ovarian cancer	7.05e-06	0.000119	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.99e-06	0.000118	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—ovarian cancer	6.93e-06	0.000117	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—ovarian cancer	6.84e-06	0.000116	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—ovarian cancer	6.84e-06	0.000116	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1B1—ovarian cancer	6.84e-06	0.000116	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—FASN—ovarian cancer	6.74e-06	0.000114	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.63e-06	0.000112	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—ovarian cancer	6.59e-06	0.000111	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—FASN—ovarian cancer	6.58e-06	0.000111	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.58e-06	0.000111	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—ovarian cancer	6.58e-06	0.000111	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.56e-06	0.000111	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.47e-06	0.000109	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—ovarian cancer	6.42e-06	0.000109	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.41e-06	0.000108	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	6.37e-06	0.000108	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—ovarian cancer	6.32e-06	0.000107	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.27e-06	0.000106	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.25e-06	0.000106	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—FASN—ovarian cancer	6.15e-06	0.000104	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.14e-06	0.000104	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPP2R1A—ovarian cancer	6.07e-06	0.000103	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—ovarian cancer	6.07e-06	0.000103	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.05e-06	0.000102	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.04e-06	0.000102	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.99e-06	0.000101	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—ovarian cancer	5.99e-06	0.000101	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—ovarian cancer	5.92e-06	0.0001	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—ovarian cancer	5.91e-06	9.99e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—ovarian cancer	5.88e-06	9.94e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.84e-06	9.87e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—ovarian cancer	5.79e-06	9.78e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.73e-06	9.68e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.72e-06	9.66e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—ovarian cancer	5.7e-06	9.64e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—ovarian cancer	5.67e-06	9.57e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—ovarian cancer	5.63e-06	9.52e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.6e-06	9.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—ovarian cancer	5.53e-06	9.35e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—ovarian cancer	5.5e-06	9.3e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.45e-06	9.2e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.42e-06	9.16e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK1—ovarian cancer	5.39e-06	9.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.32e-06	8.98e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—ovarian cancer	5.29e-06	8.94e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—ovarian cancer	5.28e-06	8.91e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—ovarian cancer	5.09e-06	8.6e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.06e-06	8.55e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—ovarian cancer	5.05e-06	8.54e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.04e-06	8.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—YAP1—ovarian cancer	4.97e-06	8.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—ovarian cancer	4.97e-06	8.39e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.97e-06	8.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—ovarian cancer	4.95e-06	8.37e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.94e-06	8.35e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—ovarian cancer	4.91e-06	8.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—ovarian cancer	4.85e-06	8.19e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK1—ovarian cancer	4.81e-06	8.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—ovarian cancer	4.81e-06	8.12e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—ovarian cancer	4.81e-06	8.12e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—ovarian cancer	4.68e-06	7.91e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—ovarian cancer	4.66e-06	7.87e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—ovarian cancer	4.65e-06	7.86e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.61e-06	7.79e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—ovarian cancer	4.54e-06	7.67e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—ovarian cancer	4.53e-06	7.65e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—ovarian cancer	4.53e-06	7.65e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—ovarian cancer	4.46e-06	7.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAV1—ovarian cancer	4.46e-06	7.53e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—ovarian cancer	4.36e-06	7.36e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—ovarian cancer	4.33e-06	7.31e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.26e-06	7.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—ovarian cancer	4.17e-06	7.05e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—ovarian cancer	4.06e-06	6.86e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FASN—ovarian cancer	4.05e-06	6.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAV1—ovarian cancer	4e-06	6.76e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.99e-06	6.74e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAV1—ovarian cancer	3.91e-06	6.6e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.88e-06	6.56e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—ovarian cancer	3.86e-06	6.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.85e-06	6.51e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.82e-06	6.46e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—ovarian cancer	3.82e-06	6.46e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—ovarian cancer	3.8e-06	6.42e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—ovarian cancer	3.69e-06	6.24e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.69e-06	6.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAV1—ovarian cancer	3.65e-06	6.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.65e-06	6.16e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—ovarian cancer	3.64e-06	6.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—ovarian cancer	3.57e-06	6.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.56e-06	6.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.49e-06	5.9e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.49e-06	5.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—ovarian cancer	3.41e-06	5.76e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.32e-06	5.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.28e-06	5.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.2e-06	5.42e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.17e-06	5.36e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.13e-06	5.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—ovarian cancer	3.11e-06	5.26e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.07e-06	5.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.04e-06	5.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—ovarian cancer	2.99e-06	5.05e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.92e-06	4.94e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—ovarian cancer	2.85e-06	4.82e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.79e-06	4.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.73e-06	4.61e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—ovarian cancer	2.69e-06	4.54e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.55e-06	4.3e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—ovarian cancer	2.51e-06	4.24e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—ovarian cancer	2.41e-06	4.08e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAV1—ovarian cancer	2.41e-06	4.07e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—ovarian cancer	2.36e-06	3.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—ovarian cancer	2.2e-06	3.72e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.19e-06	3.7e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.93e-06	3.26e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—ovarian cancer	1.9e-06	3.21e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.7e-06	2.88e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.68e-06	2.84e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.66e-06	2.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.55e-06	2.62e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—ovarian cancer	1.55e-06	2.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—ovarian cancer	1.45e-06	2.45e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—ovarian cancer	1.39e-06	2.35e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—ovarian cancer	1.36e-06	2.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—ovarian cancer	1.27e-06	2.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.02e-06	1.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—ovarian cancer	8.37e-07	1.41e-05	CbGpPWpGaD
